ArticleBlood advances2025

Characterizing clinically significant extravascular hemolysis in adults with PNH on ravulizumab or eculizumab treatment.

Austin G Kulasekararaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.